VASCONCELLES MICHAEL (EVP R&D & MEDICAL AFFAIRS) reported 1 transaction at IMMUNOGEN, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/12/2024ACC: 0001104659-24-014692
Officer· EVP R&D & MEDICAL AFFAIRS
Since Dec 2022
-1.01M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.01M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.33K
Price / share
—
Trade value
—
% of position
New position
2/12/2024
1.33K→0.00
Total
Net shares
−1.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2024 | D · Disposition | −1.33K | — | — | New position | 1.33K | 0.00 |
| Total | −1.33K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
960K shares
Shares
−960K
Strike price
5.16
Held after
0.00
Exercisable
—
2/12/2024
Restricted Stock Unit
Direct
Converts to
Common Stock
50.52K shares
Shares
−50.52K
Strike price
0
Held after
0.00
Exercisable
—
2/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock960K shares | 2/12/2024 | D · Disposition | −960K | 5.16 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock50.52K shares | 2/12/2024 | D · Disposition | −50.52K | 0 | — | 0.00 |